| Patents for C07C 401 - Irradiation products of cholesterol or its derivatives; Vitamin d derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation (3,426) |
|---|
| 04/07/2005 | CA2539708A1 1,3-diaclyated,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof |
| 04/06/2005 | EP1299409B1 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 03/31/2005 | US20050070511 2-methylene-19-nor-vitamin D2 compounds |
| 03/17/2005 | US20050059641 Comprising an analog of 1,25(OH)2D3, such as 1,25(OH)2D3-3-BE or 25(OH)2D3-3-BE, wherein said analog is alkylated or acylated; for the treatment of prostate cancer and metabolic diseases, such as psoriasis |
| 03/15/2005 | US6867313 Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same |
| 03/15/2005 | CA2121678C Vitamin d amide derivatives |
| 03/10/2005 | WO2004110380A3 Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents |
| 03/09/2005 | EP1511725A1 24-SULFOXIMINE VITAMIN D sb 3 /sb COMPOUNDS |
| 03/09/2005 | EP0970948B1 Vitamin d 3? derivatives and remedies for inflammatory respiratory diseases prepared from the same |
| 03/03/2005 | WO2005018658A1 2-methylene-19-nor-vitamin d2 compounds |
| 03/03/2005 | WO2005018648A1 (20S)-1α-HYDROXY-2-METHYLENE-19-NOR-VITAMIN D3 AND ITS USES |
| 03/03/2005 | CA2535185A1 2-methylene-19-nor-vitamin d2 compounds |
| 02/24/2005 | US20050043281 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system |
| 02/24/2005 | CA2528519A1 Treatment of lung cancer with active vitamin d compounds in combination with other treatments |
| 02/22/2005 | US6858595 Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
| 02/16/2005 | CN1189465C Vitamin D3 analogs with bis C-20 side chains |
| 02/10/2005 | WO2005011706A1 2-METHYLENE-19-NOR-20(S)-25-METHYL-1α-HYDROXYCALCIFEROL AND ITS USES |
| 02/10/2005 | US20050032754 the 2-position is substituted, the steric configuration at the 20-position is native or epimerized, and the double bond at the 5-position is in E configuration; calcium metabolism regulating agent; does not cause hypercalcemia during long-term use |
| 02/10/2005 | US20050029705 Extrusion die |
| 02/10/2005 | CA2531294A1 2-methylene-19-nor-20(s)-25-methyl-1.alpha.-hydroxycalciferol and its uses |
| 01/26/2005 | EP1499324A1 Method for treating and preventing hyperparathyroidism |
| 01/26/2005 | EP0944592B1 Vitamin d3 derivatives |
| 01/20/2005 | WO2004098507A3 1,3 aclyated 24-keto-vitamin d3 compounds and methods of use thereof |
| 01/20/2005 | WO2004080467A3 Method of treating and preventing hyperparathyroidism with vitamin d2 or d4 compounds |
| 01/19/2005 | EP1497264A2 Preparation of 24-alkyl analogs of cholecalciferol and non-racemic compounds |
| 01/13/2005 | US20050009794 Crystals of a vitamin D derivative and a method for the preparation thereof |
| 01/13/2005 | US20050009792 (20S)-1alpha-hydroxy-2-methylene-19-nor-vitamin D3 and its uses |
| 01/12/2005 | EP1274680B1 Synthesis intermediate products for producing vitamin d derivatives |
| 01/06/2005 | US20050004085 Bone disorders; controlling cell differentiation, antiproliferative agents; osteoporosis; skin disorders; anticancer agents |
| 01/04/2005 | CA2151730C New crystalline form of a vitamin d analogue |
| 12/29/2004 | EP1490332A1 Method of synthesizing 1alpha-hydroxy-2-methylene-19-nor-homopreg nacalciferol |
| 12/28/2004 | US6835723 Purification including dissolving in boiled solvent, cooling solvent and dissolved product below ambient temperature, purification |
| 12/23/2004 | WO2004110380A2 Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents |
| 12/23/2004 | CA2528378A1 Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents |
| 12/22/2004 | CN1556795A 3-desoxy-vitamin D3 analog esters |
| 12/15/2004 | CN1554650A Process for the preparation of vialoguestamin d analogs |
| 12/15/2004 | CN1554351A Medicinal composite preparation including active vitamine d compound and its use |
| 12/15/2004 | CN1179938C Process for producing vitamin D analogue |
| 12/14/2004 | US6831183 Purifying the vitamin D derivative through a reverse phase chromatography and then crystallizing purified derivative from an organic solvent |
| 12/09/2004 | WO2004080922A3 Substituted vitamin d analogues and their therapeutic uses |
| 12/08/2004 | EP1482951A1 Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses |
| 11/24/2004 | CN1549803A 维生素d的类似物 Analogs of vitamin d |
| 11/23/2004 | CA2316157C Process for the preparation of vitamin d analogues |
| 11/18/2004 | WO2004098507A2 1,3 aclyated 24-keto-vitamin d3 compounds and methods of use thereof |
| 11/17/2004 | CN1176091C Vitamin D precursor of phosphine oxide |
| 11/17/2004 | CN1176072C Vitamin D3 analogs |
| 11/11/2004 | US20040224930 25-SO2-Substituted analogs of 1mu,25-dihydroxyvitamin D3 |
| 11/11/2004 | US20040224929 Novel vitamin D analogs |
| 11/10/2004 | CN1174964C Vitamin D3 Analogs |
| 11/04/2004 | US20040220418 Method of synthesizing 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol |
| 11/03/2004 | CN1173944C New vitamin-D derivatives with carbon ring or heterocyclic substitutents at C-25, process for the preparation, intermediate products and their use for producing medicaments |
| 11/03/2004 | CN1173909C 20 kinds of modified vitamin D series derivatives, preparing and drug thereof |
| 10/21/2004 | WO2004054968A3 25-so2-substituted analogs of 1alpha, 25-dihydroxyvitamin d3 (calcitriol) |
| 10/19/2004 | US6806262 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 10/13/2004 | EP1466900A1 2-substituted vitamin d derivatives |
| 10/06/2004 | EP1464640A2 20-Epi-16-ene-25-OH-D3-analogs |
| 09/30/2004 | WO2004082631A2 METHODS FOR PREPARATION AND USE OF 1α,24(S)-DIHYDROXYVITAMIN D2 |
| 09/30/2004 | WO2003106629A3 Treating vitamin d responsive diseases |
| 09/30/2004 | CA2517125A1 Methods for preparation and use of 1.alpha.,24(s)-dihydroxyvitamin d2 |
| 09/29/2004 | EP1461314A1 Epimerization of analogs of vitamin d |
| 09/29/2004 | CN1168726C Novel vitamin D analogues |
| 09/23/2004 | WO2004080922A2 Substituted vitamin d analogues and their therapeutic uses |
| 09/23/2004 | WO2004080467A2 Method of treating and preventing hyperparathyroidism with vitamin d2 or d4 compounds |
| 09/23/2004 | CA2518531A1 2-substituted vitamin d analogues and their therapeutic uses |
| 09/23/2004 | CA2517160A1 Method of treating and preventing hyperparathyroidism with vitamin d compounds |
| 09/22/2004 | EP1458678A1 A crystallization method for purification of calcipotriene |
| 09/22/2004 | CN1167678C 新颖的维生素d类似物 Novel analogues of vitamin d |
| 09/22/2004 | CN1167677C Technological process of purifying vitamin D3 |
| 09/21/2004 | US6794375 Palatable arginine compounds and uses thereof for cardiovascular health |
| 09/08/2004 | EP1453798A2 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 09/07/2004 | US6787660 Functional vitamin D derivatives and a method for determining 25-hydroxy-vitamin D and 1α, dihydroxy-vitamin D |
| 09/07/2004 | CA2166898C Novel structural analogues of vitamin d |
| 08/26/2004 | US20040167105 Osteoporosis; anticancer agents; autoimmune disease |
| 08/26/2004 | US20040167104 26,27-Homologated-20-epi-2-alkylidene-19-nor-vitamin D compounds |
| 08/25/2004 | CN1523014A Method for photoisomerizing tachysterol and its derivative into pro-vitamin D and its derivative by solidoid photosensitizer using silica gel as carrier |
| 08/18/2004 | EP1315504B1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 08/12/2004 | WO2004067504A1 2-substituted vitamin d derivative |
| 08/11/2004 | EP0805682B1 Dermatological use of vitamin d derivatives |
| 08/10/2004 | US6774251 Method of synthesizing 1α-hydroxy-2-methylene-19-nor-homopregnacalciferol |
| 07/21/2004 | CN1158081C Medicine composition containing active vitamin D compound and its use |
| 07/15/2004 | US20040138184 Crystallization method for purification of calcipotriene |
| 07/14/2004 | EP1436257A1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3 |
| 07/08/2004 | US20040132695 Catabolism Inhibitor, modulation of hormone levels; cell-proliferative disorders, cancer, dermatological disorders, parathyroid disorders, autoimmune disorders and bone disorders |
| 07/01/2004 | WO2004054968A2 25-so2-substituted analogs of 1alpha, 25-dihydroxyvitamin d3 (calcitriol) |
| 06/30/2004 | EP1433780A1 19-nor-vitamin D3 compounds with calcemic activity |
| 06/23/2004 | EP1430026A1 3-desoxy-vitamin d3 analog esters |
| 06/22/2004 | US6753435 Catalytically reduction using lindlar catalyst; alkynylation; antitumor and antiinflammatory agents |
| 06/22/2004 | CA2153422C Dehydrogenation processes and equipment therefor |
| 06/10/2004 | US20040108198 Ultraviolet irradiation apparatus for photochemical reaction and preparation process of vitamin D derivative making use of the same |
| 06/09/2004 | EP1426352A2 Intermediates for the sythesis of vitamin D and steroid derivatives |
| 06/09/2004 | EP1240137B1 Method for making 24(s)-hydroxyvitamin d 2 |
| 06/03/2004 | WO2004046097A1 A crystallization method for purification of calcipotriene |
| 06/02/2004 | CN1501803A Use of 2alpha-methyl-19-nor-20(s)-1alpha, 25-dihydroxyvitamin d3 to increase bone strength |
| 06/02/2004 | CN1152011C Vitamin D analogues and pharmaceutical uses thereof |
| 05/26/2004 | CN1150973C Ultraviolet irradiation apparatus for photochemical reaction and method for preparing vitamin D derivative using same |
| 05/19/2004 | EP1419143A1 24-sulfur-substituted analogs of 1alpha,25-dihydroxy vitamin d3 |
| 05/06/2004 | WO2004037781A1 Vitamin d analogues, compositions comprising said analogues and their use |
| 05/06/2004 | CA2500640A1 Vitamin d analogues, compositions comprising said analogues and their use |
| 05/05/2004 | CN1148347C Method for making hydroxy-25-ene-vitamin D compounds |
| 05/04/2004 | CA2090264C Method of preparing 9beta, 10alpha-5,7-diene steroids |